financetom
Business
financetom
/
Business
/
Smart meter maker Hubbell raises annual profit forecast on strong demand
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Smart meter maker Hubbell raises annual profit forecast on strong demand
Jul 30, 2024 5:50 AM

July 30 (Reuters) - Electrical equipment maker Hubbell

on Tuesday raised the lower end of its annual adjusted

profit forecast as it looks to benefit from strong demand for

its devices used in power grids.

The company now expects full-year adjusted profit to be

between $16.20 and $16.50 per share, compared with the previous

forecast of between $16.00 and $16.50 per share.

Hubbell has benefited from the modernization of the U.S.

power grid to meet the growing power demand from data centers

and as homes and businesses use more electricity for heating and

transportation.

The utility segment sales, which made up 61% of total

revenue in 2023, increased 12% in the second quarter from a year

earlier, driven by strong growth in transmission infrastructure

and grid automation.

However, sales in the electrical segment, which makes wiring

and lighting fixtures, declined 1.7%.

The Connecticut-based company reported a second-quarter

adjusted profit of $4.37 per share, above analysts' average

expectations of $4.24 per share, according to LSEG data.

Revenue rose 6% to $1.45 billion, but were below estimates

of $1.48 billion.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Worksport to Implement 1-for-10 Reverse Split to Regain Nasdaq Compliance
Worksport to Implement 1-for-10 Reverse Split to Regain Nasdaq Compliance
Mar 14, 2025
08:45 AM EDT, 03/14/2025 (MT Newswires) -- Worksport ( WKSP ) said Friday it will implement a 1-for-10 reverse stock split, effective March 18, to help regain compliance with Nasdaq's minimum bid price rule. The stock will begin trading on a split-adjusted basis on Tuesday under its existing ticker symbol, the company said. Worksport ( WKSP ) shares were down...
BP Reportedly Says It Stopped Gas Leak at West Africa Project
BP Reportedly Says It Stopped Gas Leak at West Africa Project
Mar 14, 2025
08:44 AM EDT, 03/14/2025 (MT Newswires) -- BP (BP) said it stopped a gas leak at its Greater Tortue Ahmeyim project off West Africa, multiple news outlets reported Thursday and Friday, citing the company. The A02 well is one of the four wells for GTA, and this situation had no immediate impact on ongoing production activities from the remaining wells,...
Bristol-Myers Squibb Says EU Approves Breyanzi for Relapsed, Refractory Follicular Lymphoma
Bristol-Myers Squibb Says EU Approves Breyanzi for Relapsed, Refractory Follicular Lymphoma
Mar 14, 2025
08:44 AM EDT, 03/14/2025 (MT Newswires) -- Bristol-Myers Squibb ( BMY ) said Friday that Breyanzi has received approval from the European Commission for the treatment of adult patients with relapsed or refractory follicular lymphoma. The additional approval is based on results of a phase 2 study, where Breyanzi showed a high overall response rate of 97.1% and complete response...
Korro Bio's Potential Antitrypsin Deficiency Treatment Receives US FDA Orphan Drug Designation
Korro Bio's Potential Antitrypsin Deficiency Treatment Receives US FDA Orphan Drug Designation
Mar 14, 2025
08:38 AM EDT, 03/14/2025 (MT Newswires) -- Korro Bio ( KRRO ) said Friday that the US Food and Drug Administration has granted orphan drug designation to its investigational medicine KRRO-110 for the treatment of alpha-1 antitrypsin deficiency, or AATD. AATD is a genetic disorder that can cause pulmonary emphysema and/or hepatic cirrhosis, Korro Bio ( KRRO ) said. Korro...
Copyright 2023-2026 - www.financetom.com All Rights Reserved